Organization Profile

You just read:

Clinical Data on OGX-427 Presented at the ASCO 2012 Genitourinary Cancers Symposium Provide Ongoing Evidence of Hsp27 as a Potential Therapeutic Target in Advanced Prostate Cancer

News provided by

OncoGenex Pharmaceuticals, Inc.

Feb 02, 2012, 08:01 ET